KRAS and cancer: Furthermore, the expression of K-ras, MSH2 and MLH1 in the serrated lesions from the experimental group was not significantly different compared with that of the cancer tissues from the control group (P=0.954, 0.500 and 0.861, respectively); however, a significant difference was detected in MGMT expression (P=0.002).